U.C.S. ME/CFS Act
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (May 28, 2020)
Understanding COVID-19 Subsets and ME/CFS Act or the U.C.S. ME/CFS Act
This bill requires the National Institutes of Health to support research on myalgic encephalomyelitis/chronic fatigue syndrome among COVID-19 (i.e., coronavirus disease 2019) patients and survivors. This is a serious, chronic, and multisystem disease associated with survivors of viral infections. In addition, the Department of Health and Human Services may carry out a public awareness campaign about post-viral chronic neuroimmune diseases.
What just happenedMay 28, 2020
Referred to the House Committee on Energy and Commerce.
Who’s behind it
- Introduced in HouseMay 28, 2020
- May 28, 2020IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - May 28, 2020IntroReferralIntro-H
Introduced in House
- May 28, 2020IntroReferral1000
Introduced in House